Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Raw Materials (2023 - 2024)

Historic Raw Materials for Harmony Biosciences Holdings (HRMY) over the last 2 years, with Q4 2024 value amounting to $944000.0.

  • Harmony Biosciences Holdings' Raw Materials fell 1094.34% to $944000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $944000.0, marking a year-over-year decrease of 1094.34%. This contributed to the annual value of $944000.0 for FY2024, which is 1094.34% down from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Raw Materials of $944000.0 as of Q4 2024, which was down 1094.34% from $1.0 million recorded in Q3 2024.
  • Harmony Biosciences Holdings' 5-year Raw Materials high stood at $1.1 million for Q2 2024, and its period low was $944000.0 during Q4 2024.